| """Using Epigallocatechin Gallate (EGCG) and Cognitive Training to Modulate Cognitive Performance in Patients With Fragile X Syndrome"" (TESFX)" | Estrogen Receptors Beta (ER-B) as Therapeutic Targets for the Improvement of Cognitive Performance in Fragile-X (TESXF) | NCT01855971 |
| Anti-sebum efficacy of moisturizer containing 2%L-carnitine and 5%epigallocatechin gallate for treatment of seborrhea | Anti-sebum efficacy of moisturizer containing 2%L-carnitine and 5%epigallocatechin gallate for treatment of seborrhea | TCTR20210908003 |
| Epigallocatechin as an immunomodulatory and antineoplastic treatment in elderly patients with acute leukemia or mielodysplasia | Epigallocatechin (EGCG) as an immunomodulatory and antineoplastic treatment in elderly patients with AML or high-risk MDS inelegible for high-dose conventional chemotherapy | RBR-3nvjx2k |
| Study of Oral Epigallocatechin-3-gallate (EGCG) in IPF Patients | Dose Ranging Study of Oral Epigallocatechin-3-gallate (EGCG) Given Daily for 12 Weeks to Patients With Idiopathic Pulmonary Fibrosis (IPF) Evaluating Safety, PK Interactions With Standard of Care Drugs, and Biomarkers of Drug Effect | NCT05195918 |
| The Effect of the Association EGCG, Folic Acid and Vitamin B12 in Preventing the Persistence of HPV Infection. | A Pilot Study to Test the Effect of the Association of Epigallocatechin Gallate (EGCG), Folic Acid and Vitamin B12 in Preventing the Persistence of Human Papilloma Virus (HPV) Infection. | NCT06285357 |
| Efficacy of a maintenance therapy with supplements containing indole-3-carbinol (I3C) and epigallocatechin-3-gallate (EGCG) in ovarian cancer patients | An open randomized controlled clinical trial to evaluate the efficacy of a maintenance therapy with supplements containing I3C and EGCG in ovarian cancer patients | ACTRN12616000394448 |
| Normalization of dyrk1A and APP Function as an Approach to Improve Cognitive Performance and Decelerate AD Progression in DS Subjects: Epigallocatechin Gallate as Therapeutic Tool | Normalization of dyrk1A and APP Function as an Approach to Improve Cognitive Performance and Decelerate AD Progression in DS Subjects: Epigallocatechin Gallate as Therapeutic Tool | NCT01699711 |
| Epstein-Barr Virus Reactivation and the Effect of EGCG on Virus Reactivation in Remission Patients | Study of Epstein-Barr Virus Reactivation and the Effect of Dietary Supplement Epigallocatechin Gallate (EGCG) on Virus Reactivation in Remission Patients With Nasopharyngeal Carcinoma - A Randomized Trial | NCT01744587 |
| Epigallocatechin Gallate and Other Antural Compounds in HPV Infections | Treatment With Epigallcoatechin Gallate, Hyaluronic Acid, Folic Acid and Vitamin B12 in Women HPV Positive With Abnormal Cytology Tests | NCT06098456 |
| Epigallocatechin-3-gallate (EGCG) in supportive and symptomatic treatment of patients with esophageal cancer | Epigallocatechin-3-gallate (EGCG) in supportive and symptomatic treatment of patients with esophageal cancer | ChiCTR2100050444 |
| The adjunctive use of (-)-epigallocatechin gallate (EGCG) subgingival irrigating solution with scaling and root planing in the management of chronic periodontitis | The adjunctive use of (-)-epigallocatechin gallate (EGCG) subgingival irrigating solution with scaling and root planing in the management of chronic periodontitis | ChiCTR2000029831 |
| A Trial for the Treatment of Cardiac AL-Amyloidosis With the Green Tea Compound Epigallocatechin-3-gallate (TAME-AL) | A Randomised Trial for the Treatment of Cardiac AMyloid Light-chain Amyloidosis With the Green Tea Compound Epigallocatechin-3-gallate (TAME-AL) | NCT02015312 |
| Comparison of the tear level between (-)-epigallocatechin gallate (EGCG) and (-)-epigallocatechin 3-O-(3-O-methyl) gallate (EGCG3"Me) after oral administration in healthy volunteers. | Comparison of the tear level between (-)-epigallocatechin gallate (EGCG) and (-)-epigallocatechin 3-O-(3-O-methyl) gallate (EGCG3"Me) after oral administration in healthy volunteers. - Comparison of the tear level in green tea catechins after oral administration in healthy volunteers. | JPRN-UMIN000034291 |
| The effect of a substance in Green tea in the decrease of compounds formed in the food preparation process that affect human health | Effect of Epigallocatechin-3-Gallate on serum concentrations of Carboxymethyl-Lysine in Inflammation, Insulin Resistance and Endothelial dysfunction caused by acute ingestion of a meal high in advanced glycation end products | RBR-2b8p4n |
| Effect of the use of a catechin from green tea on the clinical performance of adhesives for dental restorations | Effect of epigallocatechin-3-gallate (EGCG) in the clinical performance of an universal adhesive system: a randomized clinical study. | RBR-2hr94r |
| Effect of Epigallocatechin -3-gallate Supplementation in Traumatic Brain Injury Patients | Effect of Green Tea Epigallocatechin -3-gallate Supplementation on Traumatic Brain Injury Patients' Outcomes | NCT02731495 |
| Effects of EGCG (Epigallocatechin Gallate) in Chorea Huntington | Effects of EGCG (Epigallocatechin Gallate) in Chorea Huntington - ETON | EUCTR2010-023941-31-DE |
| Study of Epigallocatechin-3-gallate (EGCG) for Esophagus Protection in Patients With Lung Cancer Receiving Radial Radiotherapy | | NCT02577393 |
| Study of Epigallocatechin-3-gallate (EGCG) for Skin Prevention in Patients With Breast Cancer Receiving Adjuvant Radiotherapy | Phase II Study of Topical Epigallocatechin-3-gallate (EGCG) in Patients With Breast Cancer Receiving Adjuvant Radiotherapy | NCT02580279 |
| Treatment of cardiac amyloid light-chain amyloidosis with the green tea compound epigallocatechin-3-galiate | A randomised trial for the Treatment of cardiac AMyloid light-chain amyloidosis with the green tea compound Epigallocatechin-3-gALlate (TAME-AL) | ISRCTN68399350 |
| Effects of glutamine and epigallocatechin-3-gallate on glucose tolerance, markers of inflammation, oxidative stress and procoagulant status in Type 2 diabetes mellitus | Effects of glutamine and epigallocatechin-3-gallate on glucose tolerance, markers of inflammation, oxidative stress and procoagulant status in Type 2 diabetes mellitus - Glutamine and EGCG in type 2 diabetes mellitus | NL-OMON38189 |
| Epigallocatechingallate (EGCG) in Cardiac AL Amyloidosis | A Phase II Open-label Randomized Study of Dietary Supplement With Epigallocatechin Gallate (EGCG) to Improve Cardiac Dysfunction in Patients With AL Amyloidosis Who do Not Require Chemotherapy (EpiCardiAL) | NCT01511263 |
| Treatment of Endometriosis with Epigallocatechin gallate: a double-blind randomized placebo-controlled crossover pilot trial. | Treatment of Endometriosis with Epigallocatechin gallate: a double-blind randomized placebo-controlled crossover pilot trial. - TEE- study | NL-OMON39170 |
| EGCG Improves Acne by Modulating Molecular Targets | Epigallocatechin-3-Gallate Improves Acne in Humans by Modulating Intracellular Molecular Targets and Inhibiting P. Acnes | NCT01687556 |
| Study of Epigallocatechin-3-gallate (EGCG) for Supportive and Symptomatic Management in Patients With Esophageal Cancer | Study of Epigallocatechin-3-gallate (EGCG) for Supportive and Symptomatic Management in Patients With Esophageal Cancer | NCT05039983 |
| A trial investigating the use of Veregen (EPIgallocatechin-3-gallate) in the treatment of Vulval Intraepithelial Neoplasia | Phase II clinical trial investigating the use of EPIgallocatechin-3-gallate (Veregen) in the treatment of Vulval Intraepithelial Neoplasia | ISRCTN98495886 |
| Effect of epigallocatechin on antibody-producing ability and immunostimulatory activity after influenza vaccination | Effect of epigallocatechin on antibody-producing ability and immunostimulatory activity after influenza vaccination - Epigallocatechin and immune response to influenza vaccination | JPRN-UMIN000012941 |
| Role of Epigallocatechin for the Prevention of Infections in Patients Treated with ImmunoSuppressive Therapy | Role of Epigallocatechin for the Prevention of Infections in Patients Treated with ImmunoSuppressive Therapy - Role of EpigalloCAtechin for the prevention of infections in patients treated with immunoSuppressive Therapy (RECAST) | JPRN-UMIN000013344 |
| Effect of epigallocatechin gallate on postprandial blood glucose and insulin level | Effect of epigallocatechin gallate on postprandial blood glucose and insulin level | ChiCTR2400085567 |
| Influence of Piperine on the bioavailability of epicatechin and epigallocatechin - a pilot study | Influence of Piperine on the bioavailability of epicatechin and epigallocatechin - a pilot study - E-Pip-Pilot | DRKS00020741 |
| Comparative Evaluation of Nanohydroxyapatite & EGCG mix versus Biodentine for Indirect Pulp Therapy in Young Permanent Teeth | Comparative Evaluation Of Indirect Pulp Therapy In Young Permanent Teeth Using Nanohydroxyapatite And Epigallocatechin-3-Gallate (EGCG) Mix Versus Biodentine: A Randomized Controlled Trial - NIL | CTRI/2025/03/082145 |
| Curcumin and EGCG Supplementation to Improve Serum BDNF and Mood Disturbance | A Randomized Controlled Trial to Determine the Effects of Curcumin and Epigallocatechin Gallate Supplementation on Serum Brain Derived Neurotrophic Factor and Mood Disturbance in Adults | NCT06531863 |
| A Phase II Clinical Study of Epigallocatechin-3-gallate in Patients With Esophageal Squamous Cancer | Efficacy and Safety of Epigallocatechin-3-gallate, an Important Polyphenolic That Originates From Tea, in Patients With Esophageal Squamous Cancer: A Phase II Trial | NCT06398405 |
| Evaluation of Oral EGCG Treatment for L-SIL Associated With HPV Infection | Evaluation of Oral Epigallocatechin Gallate Treatment for Low-grade Cervical Lesions (L-SIL) Associated With Human Papilloma Virus (HPV) Infection | NCT06314113 |
| Reducing Frailty for Older Cancer Survivors Using Supplements II | A Phase 2 Randomized Controlled Trial of Epigallocatechin-3-Gallate (EGCG) on Frailty and Inflammation in Older Survivors of Cancer | NCT06068543 |
| The effect of epigallocatechin gallate loaded nanostructured lipid carriers on oral lichen planus | The effect of epigallocatechin gallate (extracted from green tea) loaded nanostructured lipid carriers on the treatment of oral lichen planus | IRCT20230823059238N1 |
| EGCG for Hepatocellular Carcinoma Chemoprevention | Phase II Randomized Controlled Trial of Epigallocatechin Gallate for Hepatocellular Carcinoma Chemoprevention | NCT06015022 |
| Effects of treatment with FOPCON in patients with Fibrodysplasia Ossificans Progressiva | Clinical, biochemical and molecular aspects in patients with Fibrodysplasia Ossificans Progressiva before and after treatment with ascorbic acid, propranolol, hesperidine and epigallocatechin | RBR-9dkn9ry |
| Effect of Epigallocatechin-3-Gallate Solution as a Root Canal Irrigant on Post-Operative Pain Intensity and Bacterial Load Reduction in Necrotic Tooth | Effect of Epigallocatechin-3-Gallate Solution Versus Sodium Hypochlorite as a Root Canal Irrigant on Post-Operative Pain Intensity and Bacterial Load Reduction in Asymptomatic Necrotic Mandibular Premolars: A Randomized Clinical Trial | NCT05988788 |
| Epigallocatechin Gallate (EGCG) as a Flushing Agent During Full Pulpotomy in Mature Permanent Molars With Irreversible Pulpitis | The Influence of Epigallocatechin Gallate (EGCG) as a Flushing Agent During Full Pulpotomy Using Two Different Calcium Silicate-based Materials on Postoperative Pain and Success Rate in Mature Permanent Molars With Irreversible Pulpitis: A Randomized Clinical Trial | NCT05811403 |
| Comparative Efficacy of Gingival Application of Injectable Platelet Concentrate and Green Tea Gel as an Add-On in the treatment of Periodontitis | Comparative Efficacy of Local Subgingival Application of Injectable Platelet Rich Fibrin and (-)-Epigallocatechin Gallate Gel as an Adjunct to Scaling and Root Planing: A Randomized Controlled Clinical Trial | CTRI/2022/09/045964 |
| SUNIMUD - Sunphenon EGCg (Epigallocatechin-Gallate) in Duchenne Muscular Dystrophy | SUNIMUD - Sunphenon EGCg (Epigallocatechin-Gallate) in Duchenne Muscular Dystrophy - SUNIMUD | EUCTR2009-016482-28-DE |
| Vitamin D, Epigallocatechin Gallate, D-chiro-inositol and Vitamin B6 in Uterine Fibroid | The Use of Vitamin D in Combination with Epigallocatechin Gallate, D-chiro-inositol and Vitamin B6 in the Treatment of Women with Uterine Fibroid | NCT05448365 |
| Efficacy and Safety of Cream containing Dipotassium Glycyrrhizinate, Vaccinium Myrtillius, Epigallocatechin Gallatyl Glucoside, Tamarindus Indica Compared with Triamcinolone acetonide Cream in the treatment of eczema and plaque psoriasis | Efficacy and Safety of Cream containing Dipotassium Glycyrrhizinate, Vaccinium Myrtillius, Epigallocatechin Gallatyl Glucoside, Tamarindus Indica Compared with Triamcinolone acetonide Cream in the treatment of eczema and plaque psoriasis | TCTR20211025002 |
| Effect of Bromelain , Curcumin and Epigallocatechin in the treatment of outpatient Covid-19 patients | A Randomized, Double-blind, Placebo-controlled study to Evaluate the Efficacy and Safety of the Bromelain, Curcumin and Epigallocatechin in the treatment of outpatient Covid-19 patients | IRCT20210724051971N1 |
| Reducing Frailty for Older Cancer Survivors Using Supplements | Reducing Frailty for Older Cancer Survivors Using Supplements (ReFOCUS): A Phase 2 Randomized Controlled Trial of Epigallocatechin-3-Gallate (EGCG) on Frailty and Inflammation in Older Survivors of Cancer | NCT04553666 |
| Clinical evaluation of the effect of epigallocatechin-3-gallate in the restorative treatment of non-carious lesions | Clinical evaluation of the effect of Epigallocatechin-3-gallate in the restorative treatment of Abfraction lesions | RBR-772thc |
| Effects of epigallocatechin gallate (EGCG) and Cissus Quadrangularis extract on adiposity, metabolic profiles, serum leptin, and resting metabolic rate | Effects of epigallocatechin gallate (EGCG) and Cissus Quadrangularis extract on adiposity, metabolic profiles, serum leptin, and resting metabolic rate | TCTR20200422001 |
| The effect of chlorhexidine and Epigallocatechin Gallate in ultrasonic instrumentation of advanced periodontitis patients | The effect of chlorhexidine and Epigallocatechin Gallate in ultrasonic instrumentation of advanced periodontitis patients | ChiCTR2000029911 |
| Effect of Epigallocatechin Gallate supplementation on type 2 diabetes | Effects of Epigallocatechin Gallate Supplementation on the Insulin Resistence and Inflammatory Factors in Patients with Type 2 Diabetes | IRCT20181219042047N1 |
| Impact of Ketone Bodies and Epigallocatechin Gallate in Multiple Sclerosis | Impact of Ketone Bodies and Epigallocatechin Gallate in Multiple Sclerosis | NCT03740295 |
| Effect of Green Tea on Stroke | The effect of powdered green tea enriched with epigallocatechin gallate (EGCG) on some clinical, biochemical, inflammatory, antioxidant and cognitive parameters in stroke patients; a double-blind, placebo-controlled clinical trial | IRCT20180902040927N1 |
| Effect of Epigallocatechin Gallate supplementation on type 2 diabetes | Studing the effects of Epigallocatechin Gallate supplementation on lipid profile, Insulin resistance, Oxidative stress and inflammatory factors in rs9939609 FTO gene variants in type 2 diabetic patients. | IRCT2017021612949N3 |
| Chemopreventive Effects of Epigallocatechin Gallate (EGCG) in Colorectal Cancer (CRC) Patients | A Pilot Study to Evaluate the Chemopreventive Effects of Epigallocatechin Gallate (EGCG) in Colorectal Cancer (CRC) Patients with Curative Resections. | NCT02891538 |
| Epigallocatechin Gallate Lowers Circulating Catecholamine Concentrations and Alters Lipid Metabolism. | The Polyphenol Epigallocatechin Gallate Lowers Circulating Catecholamine Concentrations and Alters Lipid Metabolism During Graded Exercise in Man. | NCT03199430 |
| Epigallocatechin Gallate (EGCG) to Improve Cognitive Performance in Foetal Alcohol Syndrome (FAS) Children | Epigallocatechin Gallate (EGCG) as Therapeutic Tool to Improve Cognitive Performance in Foetal Alcohol Syndrome (FAS) Children | NCT02558933 |
| Effects of Vitamin D, Epigallocatechin Gallate, Vitamin B6, and D-Chiro-inositol Combination on Uterine Fibroids | Effects of Vitamin D, Epigallocatechin Gallate, Vitamin B6, and D-Chiro-inositol Combination on Uterine Fibroids: a Randomized Controlled Trial | NCT05409872 |
| Effects of Epigallocatechin Gallate (EGCG) in Healthy, Young Adults | Cerebral Blood Flow, Cerebro-electrical Activity and Behavioural Effects of Epigallocatechin Gallate (EGCG) Administration in Healthy, Young Adults | NCT00981292 |
| Effect of EGCG on the Body's Response to Insulin | An Exploratory Study to Evaluate the Ability of Epigallocatechin Gallate to Simultaneously Improve Metabolic and Cardiovascular Actions of Insulin in Healthy and Obese Subjects | NCT00434499 |
| Sunphenon EGCg (Epigallocatechin-Gallat) in the early stage of Alzheimer´s Disease - SUN-AK | Sunphenon EGCg (Epigallocatechin-Gallat) in the early stage of Alzheimer´s Disease - SUN-AK | EUCTR2009-009656-20-DE |
| Green Tea, High in Epigallocatechin Gallate (EGCG) and Postprandial Fat Oxidation | Effects of the Green Tea Extract TEAVIGO High in EGCG, on Postprandial Fat Oxidation in Overweight Volunteers | NCT00867555 |
| Sunphenon (Epigallocatechin-Gallate) in relapsing-remitting multiple sclerosis - Sunphenon in RR-MS | Sunphenon (Epigallocatechin-Gallate) in relapsing-remitting multiple sclerosis - Sunphenon in RR-MS | EUCTR2006-006323-39-DE |
| Effect of Epigallocatechin-Gallate on Inner Retinal Function in Ocular Hypertension and Early Glaucoma | Functional Effects of Epigallocatechingallate on Retinal Function in Glaucoma | NCT00476138 |
| Sunphenon EGCg (Epigallocatechin-Gallate) in the Early Stage of Alzheimer´s Disease | Sunphenon EGCg (Epigallocatechin-Gallate) in the Early Stage of Alzheimer´s Disease | NCT00951834 |
| The acute effects of a green tea extract, -Epigallocatechin Gallate (EGCG) on cognition, stress, brain function and cardiovascular function. | An investigation into the acute effects of -Epigallocatechin Gallate (EGCG) on cognition, stress, brain function and cardiovascular function in healthy adults. | ACTRN12609000646246 |
| Behandeling van endometriose met groene thee: Een dubbel blind gerandomiseerde placebo gecontroleerde pilot studie. | Treatment of endometriosis with epigallocatechin gallate: A double-blind randomized placebo-controlled pilot trial. | NL-OMON20203 |
| Sunphenon in Progressive Forms of Multiple Sclerosis | Monocentric, Prospective, Doubleblind, Randomised/Stratified, Placebocontrolled Two-arm Study to Evaluate the Effect of Sunphenon EGCg (Main Component Epigallocatechin-Gallat) on the Increase of Brain Atrophy in the Cerebral Magnetic Resonance Tomography in a 36-months Treatment Time in Patients With Primary or Secondary Chronic-progressive Multiple Sclerosis | NCT00799890 |
| Sunphenon Epigallocatechin-Gallate (EGCg) in Duchenne Muscular Dystrophy | Sunphenon Epigallocatechin-Gallate (EGCg) in Duchenne Muscular Dystrophy | NCT01183767 |
